Trials / Completed
CompletedNCT06741111
A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,233,970 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to estimate the proportion of people with low/intermediate/high risk of advanced fibrosis in at risk Chinese population based on the European Association for the Study of the Liver (EASL) 2024 care pathway
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2025-01-21
- Primary completion
- 2025-05-27
- Completion
- 2025-05-27
- First posted
- 2024-12-18
- Last updated
- 2025-06-22
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT06741111. Inclusion in this directory is not an endorsement.